Fabio Vieira Teixeira

12PUBLICATIONS
70CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological methodsInnate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 19, 2025
Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safety.

Rogério Serafim Parra, Renata de Sá Brito Fróes, Daniela Oliveira Magro

|Jul 24, 2024
ARE WE READY FOR MULTIPLE SWITCHES BETWEEN REFERENCE PRODUCTS AND BIOSIMILARS?

Fabio Vieira Teixeira, Laurent Peyrin-Biroulet, Silvio Danese

|Apr 29, 2024
Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study.

Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Matheus Freitas Cardoso de Azevedo

|Feb 13, 2023
Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study.

Ramir Luan Perin, Daniela Oliveira Magro, Adriana Ribas Andrade

|Apr 28, 2021
BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.

Natália Sousa Freitas Queiroz, Fábio Vieira Teixeira, Caio Cesar Furtado Freire

Pageof 2